PriceTargets.com logo

Aurora Cannabis - ACB Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: C$9.25
  • Forecasted Upside: 98.92%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
C$4.65 As of 03/19/2026 05:00 PM ET
▼ -0.07 (-1.48%)

This chart shows the closing price for ACB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Aurora Cannabis Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ACB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ACB

Analyst Price Target is C$9.25
▲ +98.92% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Aurora Cannabis in the last 3 months. The average price target is C$9.25, with a high forecast of C$10.00 and a low forecast of C$8.50. The average price target represents a 98.92% upside from the last price of C$4.65.

This chart shows the closing price for ACB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 2 investment analysts is to buy stock in Aurora Cannabis. This rating has held steady since November 2025, when it changed from a Strong Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
9/25/2024
  • 1 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
12/24/2024
  • 2 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/24/2025
  • 2 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/22/2025
  • 2 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/20/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/19/2025
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/17/2026
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/19/2026

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/27/2026Canaccord Genuity GroupSet TargetBuyC$10.00
12/11/2025ATB Cormark Capital MarketsLower TargetOutperformC$9.00 ➝ C$8.50
2/5/2025ATB Cormark Capital MarketsUpgradeHold ➝ Strong-Buy
12/17/2024ATB Cormark Capital MarketsLower TargetC$11.00 ➝ C$8.50
12/12/2024TD SecuritiesUpgradeStrong-Buy
12/11/2024TD SecuritiesSet TargetBuyC$9.00
6/21/2024ATB Cormark Capital MarketsLower TargetSector PerformC$12.50 ➝ C$11.00
2/27/2024Jefferies Financial GroupLower TargetHoldC$6.12 ➝ C$4.95
2/21/2024Canadian Imperial Bank of CommerceLower TargetNeutralC$6.00
2/9/2024Canaccord Genuity GroupUpgradeHold ➝ BuyC$0.80
11/21/2023Jefferies Financial GroupLower TargetHoldC$0.69 ➝ C$0.61
11/16/2023Canadian Imperial Bank of CommerceLower TargetNeutralC$0.85 ➝ C$0.80
8/29/2023Canadian Imperial Bank of CommerceLower TargetNeutralC$1.00 ➝ C$0.85
8/11/2023TD CowenLower TargetC$1.00 ➝ C$0.80
6/22/2023Jefferies Financial GroupLower TargetC$1.31 ➝ C$0.72
6/16/2023Canadian Imperial Bank of CommerceLower TargetC$1.75 ➝ C$1.00
6/16/2023TD SecuritiesLower TargetC$1.30 ➝ C$1.00
6/15/2023Canaccord Genuity GroupLower TargetC$1.50 ➝ C$0.80
6/15/2023ATB Cormark Capital MarketsLower TargetC$1.80 ➝ C$1.50
2/28/2023Jefferies Financial GroupLower TargetC$1.80 ➝ C$1.31
2/13/2023Canadian Imperial Bank of CommerceLower TargetNeutralC$2.25 ➝ C$1.75
2/13/2023Stifel NicolausLower TargetC$1.45 ➝ C$1.20
2/10/2023Canaccord Genuity GroupLower TargetC$2.00 ➝ C$1.50
1/27/2023Stifel NicolausLower TargetC$1.75 ➝ C$1.45
9/28/2022Jefferies Financial GroupLower TargetC$4.10 ➝ C$1.50
9/22/2022Stifel NicolausLower TargetC$2.15 ➝ C$1.75
9/22/2022ATB Cormark Capital MarketsUpgradeUnderperform ➝ Sector PerformC$3.00 ➝ C$4.00
9/21/2022ATB Cormark Capital MarketsUpgradeUnderperform ➝ Sector Perform
9/21/2022Canaccord Genuity GroupUpgradeSell ➝ HoldC$2.50 ➝ C$2.00
9/21/2022Piper SandlerLower TargetNeutralC$4.00
9/19/2022Canadian Imperial Bank of CommerceLower TargetNeutralC$3.75 ➝ C$2.50
6/6/2022Stifel NicolausUpgradeSell ➝ HoldC$2.50 ➝ C$2.15
5/16/2022Canadian Imperial Bank of CommerceLower TargetC$6.50 ➝ C$3.75
5/13/2022Piper SandlerLower TargetHoldC$7.00 ➝ C$4.00
5/13/2022MKM PartnersReiterated RatingHoldC$6.50 ➝ C$3.00
5/10/2022ATB Cormark Capital MarketsLower TargetUnderperformC$5.00 ➝ C$4.00
5/2/2022Stifel NicolausLower TargetC$3.50 ➝ C$3.00
2/11/2022Canaccord Genuity GroupLower TargetC$6.00 ➝ C$5.00
2/11/2022Piper SandlerReiterated RatingHoldC$5.00 ➝ C$7.00
2/11/2022MKM PartnersReiterated RatingHoldC$6.00 ➝ C$6.50
2/11/2022TD CowenLower TargetNeutralC$10.00 ➝ C$7.00
2/8/2022MKM PartnersLower TargetSellC$8.00 ➝ C$6.00
2/3/2022Canadian Imperial Bank of CommerceLower TargetC$9.25 ➝ C$6.50
11/12/2021MKM PartnersBoost TargetSellC$7.00 ➝ C$8.00
11/10/2021TD CowenBoost TargetC$10.00
11/10/2021Canadian Imperial Bank of CommerceUpgradeUnderperform ➝ HoldC$6.50 ➝ C$9.25
10/1/2021Jefferies Financial GroupReiterated RatingHold
9/30/2021Jefferies Financial GroupLower TargetNAC$8.56 ➝ C$7.50
9/30/2021Canadian Imperial Bank of CommerceLower TargetUnderperformC$7.00 ➝ C$6.50
9/29/2021ATB Cormark Capital MarketsLower TargetSector PerformC$7.50 ➝ C$6.00
9/28/2021Piper SandlerReiterated RatingHoldC$7.00
9/24/2021Canadian Imperial Bank of CommerceReiterated RatingUnderperformC$7.00 ➝ C$6.50
9/23/2021Canadian Imperial Bank of CommerceLower TargetNAC$8.00 ➝ C$7.00
9/20/2021MKM PartnersLower TargetSellC$9.00 ➝ C$6.00
9/3/2021Jefferies Financial GroupUpgradeHoldC$9.44 ➝ C$6.78
7/23/2021ATB Cormark Capital MarketsReiterated RatingUnderperform
5/17/2021Stifel NicolausLower TargetNAC$7.80 ➝ C$6.50
5/17/2021Canadian Imperial Bank of CommerceLower TargetUnderperformC$9.00 ➝ C$8.00
5/14/2021TD CowenLower TargetNAC$16.00 ➝ C$8.50
5/14/2021MKM PartnersLower TargetNAC$9.00 ➝ C$6.00
5/14/2021ATB Cormark Capital MarketsDowngradeSector Perform ➝ UnderperformC$13.00
5/13/2021ATB Cormark Capital MarketsDowngradeSector Perform ➝ Underperform
5/11/2021Canadian Imperial Bank of CommerceLower TargetNeutral ➝ UnderperformC$15.00 ➝ C$9.00
5/11/2021Royal Bank Of CanadaDowngradeUnderperform
(Data available from 3/19/2021 forward)

News Sentiment Rating

0.53 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/21/2025
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/20/2025
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/20/2025
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/19/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/19/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/18/2026
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/17/2026
  • 2 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
3/19/2026

Current Sentiment

  • 2 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Aurora Cannabis logo
Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.
Read More

Today's Range

Now: C$4.65
Low: C$4.56
High: C$4.70

50 Day Range

MA: C$5.25
Low: C$4.52
High: C$6.08

52 Week Range

Now: C$4.65
Low: C$4.50
High: C$9.33

Volume

252,487 shs

Average Volume

408,188 shs

Market Capitalization

C$263.70 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.258979

Frequently Asked Questions

What sell-side analysts currently cover shares of Aurora Cannabis?

The following Wall Street analysts have issued research reports on Aurora Cannabis in the last year: ATB Cormark Capital Markets, and Canaccord Genuity Group Inc..
View the latest analyst ratings for ACB.

What is the current price target for Aurora Cannabis?

0 Wall Street analysts have set twelve-month price targets for Aurora Cannabis in the last year. Their average twelve-month price target is C$9.25, suggesting a possible upside of 96.0%. Canaccord Genuity Group Inc. has the highest price target set, predicting ACB will reach C$10.00 in the next twelve months. ATB Cormark Capital Markets has the lowest price target set, forecasting a price of C$8.50 for Aurora Cannabis in the next year.
View the latest price targets for ACB.

What is the current consensus analyst rating for Aurora Cannabis?

Aurora Cannabis currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ACB will outperform the market and that investors should add to their positions of Aurora Cannabis.
View the latest ratings for ACB.

What other companies compete with Aurora Cannabis?

Other companies that are similar to Aurora Cannabis include DRI Healthcare Trust, Hydropothecary, Knight Therapeutics, Canopy Growth and Cipher Pharmaceuticals. Learn More about companies similar to Aurora Cannabis.

How do I contact Aurora Cannabis' investor relations team?

Aurora Cannabis' physical mailing address is 1500 - 1199 West Hastings St., VANCOUVER, BC V6E 3T5, Canada. The company's listed phone number is +1-604-3625207. The official website for Aurora Cannabis is auroramj.com. Learn More about contacing Aurora Cannabis investor relations.